These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34783452)

  • 21. Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp.
    Kulp J; Levy S; Fein MC; Adams M; Furst J; Meng TC
    Arch Dermatol Res; 2010 Sep; 302(7):539-44. PubMed ID: 20204654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 23. Reflectance confocal microscopy as noninvasive tool for monitoring tirbanibulin efficacy in actinic keratosis.
    Venturi F; Veronesi G; Baraldi C; Dika E
    Photodiagnosis Photodyn Ther; 2024 Aug; 48():104235. PubMed ID: 38851311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland.
    Dymond A; Green W; Edwards M; Pont MAL; Gupta G
    Pharmacoecon Open; 2023 May; 7(3):443-454. PubMed ID: 37012513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
    Mohney L; Singh R; Grada A; Feldman S
    J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Heppt MV; Dykukha I; Graziadio S; Salido-Vallejo R; Chapman-Rounds M; Edwards M
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tirbanibulin: First Approval.
    Markham A; Duggan S
    Drugs; 2021 Mar; 81(4):509-513. PubMed ID: 33713299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.
    Nazzaro G; Carugno A; Bortoluzzi P; Buffon S; Astrua C; Zappia E; Trovato E; Caccavale S; Pellegrino V; Paolino G; Balestri R; Lacava R; Ciccarese G; Verdelli A; Barruscotti S; Valenti M; Toni G; Giacalone S; Zavattaro E; Gironi LC; Mercuri SR; Ribero S; Gisondi P; Sena P; Marzano AV
    Int J Dermatol; 2024 Apr; ():. PubMed ID: 38605473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.
    Hanke CW; Berman B; Swanson N; Pariser DM; Weiss JS; Bukhalo M; Skov T; Villumsen J; Siegel D
    J Drugs Dermatol; 2017 May; 16(5):438-444. PubMed ID: 28628679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.
    Hong JB; Wu PY; Qin A; Huang YW; Tseng KC; Lai CY; Chan WK; Fang J; Cutler DL; Tsai TF
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tirbanibulin: A New Topical Therapy for Actinic Keratoses With a Novel Mechanism of Action and Improved Ease of Use.
    Gilchrest BA
    Clin Pharmacol Drug Dev; 2021 Oct; 10(10):1126-1129. PubMed ID: 34612001
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
    Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
    Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.
    Mansilla-Polo M; Abril-Pérez C; Martín-Torregrosa D; López-Davia J; de Unamuno-Bustos B; Torres-Navarro I; Escutia-Muñoz B; Botella-Estrada R
    Australas J Dermatol; 2023 Nov; 64(4):560-564. PubMed ID: 37675890
    [No Abstract]   [Full Text] [Related]  

  • 35. A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.
    Weiss J; Ulrich M; Bukhalo M; Østerdal ML; Bang B; Hanke CW
    Br J Dermatol; 2017 Jun; 176(6):1456-1464. PubMed ID: 28078678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin Type.
    Alomar A; Stockfleth E; Dirschka T; Gupta G; Aractingi S; Dakovic R; Peris K
    J Drugs Dermatol; 2016 Mar; 15(3):285-9. PubMed ID: 26954313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience.
    Li Pomi F; Peterle L; d'Aloja A; Di Tano A; Vaccaro M; Borgia F
    Dermatol Ther (Heidelb); 2024 Jun; 14(6):1683-1696. PubMed ID: 38740726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis.
    Gilaberte Y; Fernández-Figueras MT
    Actas Dermosifiliogr; 2022 Jan; 113(1):58-66. PubMed ID: 35249711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.